Related references
Note: Only part of the references are listed.An examination of the linear no-threshold hypothesis of cancer risk assessment: Introduction to a series of reviews documenting the lack of biological plausibility of LNT
R. Golden et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Dose-dependence of chemical carcinogenicity: Biological mechanisms for thresholds and implications for risk assessment
Rebecca A. Clewell et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Inflammation as a Cancer Co-Initiator: New Mechanistic Model Predicts Low/Negligible Risk at Noninflammatory Carcinogen Doses
Kenneth T. Bogen
DOSE-RESPONSE (2019)
Filling Data Gaps by Read-across: A Mini Review on its Application, Developments and Challenges
Simona Kovarich et al.
MOLECULAR INFORMATICS (2019)
28-Day somatic gene mutation study of 1-bromopropane in female Big Blues® B6C3F1 mice via whole-body inhalation: Support for a carcinogenic threshold
Mark Stelljesa et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)
Correlation of Noncancer Benchmark Doses in Short- and Long-Term Rodent Bioassays
Jessica Kratchman et al.
RISK ANALYSIS (2018)
Conditional Toxicity Value (CTV) Predictor: An In Silico Approach for Generating Quantitative Risk Estimates for Chemicals
Jessica A. Wignall et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2018)
Demystifying Evidence-Based Policy Analysis by Revealing Hidden Value-Laden Constraints
Adam M. Finkel
HASTINGS CENTER REPORT (2018)
Derivation of a no-significant-risk-level for tetrabromobisphenol A based on a threshold non-mutagenic cancer mode of action
Alison M. Pecquet et al.
JOURNAL OF APPLIED TOXICOLOGY (2018)
What is the meaning of 'A compound is carcinogenic'?
Dieter Schrenk
TOXICOLOGY REPORTS (2018)
Threshold and non-threshold chemical carcinogens: A survey of the present regulatory landscape
Ruth J. Bevan et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2017)
Balancing research and funding using value of information and portfolio tools for nanomaterial risk classification
Matthew E. Bates et al.
NATURE NANOTECHNOLOGY (2016)
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations
Sander Greenland et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2016)
Expert judgement and uncertainty quantification for climate change
Michael Oppenheimer et al.
NATURE CLIMATE CHANGE (2016)
Concordance of Noncarcinogenic Endpoints in Rodent Chemical Bioassays
Bing Wang et al.
RISK ANALYSIS (2015)
EPA Underestimates, Oversimplifies, Miscommunicates, and Mismanages Cancer Risks by Ignoring Human Susceptibility
Adam M. Finkel
RISK ANALYSIS (2014)
A Decision Analytic Approach to Exposure-Based Chemical Prioritization
Jade Mitchell et al.
PLOS ONE (2013)
LINEAR NON-THRESHOLD: SEPARATING FACTS FROM FICTION
A. Alan Moghissi et al.
DOSE-RESPONSE (2012)
Rethink chemical risk assessments
George M. Gray et al.
NATURE (2012)
Solution-Focused Risk Assessment: A Proposal for the Fusion of Environmental Analysis and Action
Adam M. Finkel
HUMAN AND ECOLOGICAL RISK ASSESSMENT (2011)
What's wrong with risk matrices?
Louis Anthony (Tony) Cox
RISK ANALYSIS (2008)
Dose-dependent transitions in mechanisms of toxicity: case studies
W Slikker et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Tiered chemical testing: A value of information approach
F Yokota et al.
RISK ANALYSIS (2004)
Hormesis: from marginalization to mainstream - A case for hormesis as the default dose-response model in risk assessment
EJ Calabrese
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Assessing human health response in life cycle assessment using ED10s and DALYs:: Part 2 -: Noncancer effects
D Pennington et al.
RISK ANALYSIS (2002)
Limitations to empirical extrapolation studies: The case of BMD ratios
KP Brand et al.
RISK ANALYSIS (2001)
Share Paper
